NCT01367535View on ClinicalTrials.gov

Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Healthy Adults
Interventions
DRUG

SC Methylnaltrexone (MNTX)

DRUG

IV Methylnaltrexone (MNTX)

DRUG

Oral Paroxetine

DRUG

SC Placebo

Trial Locations (1)

10591

Progenics Pharmaceuticals, Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01367535 - Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan | Biotech Hunter | Biotech Hunter